CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 51 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,669,000 | +32.2% | 251,740 | +16.2% | 0.00% | +50.0% |
Q4 2021 | $4,288,000 | -13.5% | 216,574 | -14.1% | 0.00% | -33.3% |
Q3 2021 | $4,960,000 | +2.1% | 252,012 | +14.1% | 0.00% | 0.0% |
Q2 2021 | $4,859,000 | -13.7% | 220,846 | -6.7% | 0.00% | 0.0% |
Q1 2021 | $5,633,000 | -6.3% | 236,764 | +3.1% | 0.00% | -25.0% |
Q4 2020 | $6,010,000 | +38.9% | 229,746 | -7.6% | 0.00% | +33.3% |
Q3 2020 | $4,328,000 | +19.9% | 248,638 | +15.8% | 0.00% | 0.0% |
Q2 2020 | $3,611,000 | +55.9% | 214,656 | +10.2% | 0.00% | +50.0% |
Q1 2020 | $2,316,000 | +25.8% | 194,747 | +28.0% | 0.00% | +100.0% |
Q4 2019 | $1,841,000 | +12.0% | 152,182 | +30.9% | 0.00% | 0.0% |
Q3 2019 | $1,644,000 | +87.7% | 116,295 | +47.9% | 0.00% | 0.0% |
Q2 2019 | $876,000 | -51.3% | 78,607 | -48.7% | 0.00% | -50.0% |
Q1 2019 | $1,800,000 | -25.7% | 153,337 | -15.5% | 0.00% | 0.0% |
Q4 2018 | $2,423,000 | +13.7% | 181,379 | +19.3% | 0.00% | 0.0% |
Q3 2018 | $2,131,000 | -13.3% | 151,984 | -2.8% | 0.00% | 0.0% |
Q2 2018 | $2,458,000 | -25.2% | 156,368 | -21.7% | 0.00% | -33.3% |
Q1 2018 | $3,286,000 | +12.9% | 199,745 | +23.9% | 0.00% | 0.0% |
Q4 2017 | $2,911,000 | +4.2% | 161,197 | +11.4% | 0.00% | 0.0% |
Q3 2017 | $2,794,000 | +159.2% | 144,764 | +58.4% | 0.00% | +200.0% |
Q2 2017 | $1,078,000 | +129.9% | 91,383 | +113.6% | 0.00% | 0.0% |
Q1 2017 | $469,000 | +40.0% | 42,791 | -7.3% | 0.00% | – |
Q4 2016 | $335,000 | +238.4% | 46,175 | +204.6% | 0.00% | – |
Q3 2016 | $99,000 | +33.8% | 15,157 | +11.1% | 0.00% | – |
Q2 2016 | $74,000 | +21.3% | 13,640 | +4.4% | 0.00% | – |
Q1 2016 | $61,000 | +7.0% | 13,065 | +14.3% | 0.00% | – |
Q4 2015 | $57,000 | +35.7% | 11,427 | +2.7% | 0.00% | – |
Q3 2015 | $42,000 | -59.6% | 11,126 | -35.6% | 0.00% | – |
Q2 2015 | $104,000 | -66.8% | 17,270 | -69.1% | 0.00% | -100.0% |
Q1 2015 | $313,000 | +86.3% | 55,955 | +0.1% | 0.00% | – |
Q4 2014 | $168,000 | +13.5% | 55,919 | +1.2% | 0.00% | – |
Q3 2014 | $148,000 | +14.7% | 55,256 | +87.0% | 0.00% | – |
Q1 2014 | $129,000 | +35.8% | 29,555 | 0.0% | 0.00% | – |
Q4 2013 | $95,000 | +156.8% | 29,555 | +26.2% | 0.00% | – |
Q3 2013 | $37,000 | -30.2% | 23,416 | -23.4% | 0.00% | – |
Q2 2013 | $53,000 | – | 30,581 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |